Giuseppe De Luca

Showing 1-8 of 8 articles

Coronary interventions

EAPCI Core Curriculum for Percutaneous Cardiovascular Interventions (2020): Committee for Education and Training European Association of Percutaneous Cardiovascular Interventions (EAPCI) A branch of the European Society of Cardiology

Van Belle E, Teles RC, Pyxaras S, Kalpak O, Johnson T, Barbash IM, De Luca G, Kostov J, Parma R, Vincent F, Brugaletta S, Debry N, Toth G, Ghazzal Z, Deharo P, Milasinovic D, Kaspar K, Saia F, Mauri J, Kammler J, Muir D, O'Connor S, Mehilli J, Thiele H, Weilenmann D, Witt N, Joshi F, Kharbanda R, Piroth Z, Wojakowski W, Geppert A, Di Gioia G, Pires-Morais G, Petronio A, Estevez-Loureiro R, Ruzsa Z, Kefer J, Kunadian V, Van Mieghem N, Windecker S, Baumbach A, Haude M, Dudek D

July 7, 2020 | 10.4244/EIJ-D-18-00448

Coronary interventions

Final results of the randomised evaluation of short-term dual antiplatelet therapy in patients with acute coronary syndrome treated with a new-generation stent (REDUCE trial)

De Luca G, Damen S, Camaro C, Benit E, Verdoia M, Rasoul S, Liew H, Polad J, Ahmad W, Zambahari R, Postma S, Kedhi E, Suryapranata H

December 6, 2019 | 10.4244/EIJ-D-19-00539

Coronary interventions

Impact of time to treatment on the effects of bivalirudin vs. glycoprotein IIb/IIIa inhibitors and heparin in patients undergoing primary percutaneous coronary intervention: insights from the HORIZONS-AMI trial

Schoos M, De Luca G, Dangas G, Clemmensen P, Ayele G, Mehran R, Stone G

October 20, 2016 | 10.4244/EIJV12I9A186

Coronary interventions

Very high-pressure dilatation for undilatable coronary lesions: indications and results with a new dedicated balloon

Secco G, Ghione M, Mattesini A, Dall’Ara G, Ghilencea L, Kilickesmez K, De Luca G, Fattori R, Parisi R, Marino P, Lupi A, Foin N, Di Mario C

June 20, 2016 | 10.4244/EIJY15M06_04

Time-related impact of distal embolisation on myocardial perfusion and survival among patients undergoing primary angioplasty with glycoprotein IIb-IIIa inhibitors: insights from the EGYPT cooperation

De Luca G, Gibson C, Huber K, Dudek D, Cutlip D, Zeymer U, Gyöngyösi M, Bellandi F, Noc M, Arntz H-R, Maioli M, Secco G, Zorman S, Gabriel H, Emre A, Rakowski T, van’t Hof A

August 24, 2012 | 10.4244/EIJV8I4A74

Safety and efficacy of biodegradable vs. durable polymer drug-eluting stents: evidence from a meta-analysis of randomised trials

Navarese E, Kubica J, Castriota F, Gibson M, De Luca G, Buffon A, Bolognese L, Margheri M, Andreotti F, Di Mario C, De Servi S

December 30, 2011 | 10.4244/EIJV7I8A155

Optical coherence tomography for guidance of treatment of in-stent restenosis with cutting balloons

Secco G, Foin N, Msc M, Viceconte N, Borgia F, De Luca G, Di Mario C

November 30, 2011 | 10.4244/EIJV7I7A130

Percutaneous coronary stenting in patients with left ventricular systolic dysfunction: a systematic review and meta-analysis

Biondi-Zoccai G, Moretti C, Abbate A, Lipinski M, De Luca G, Agostoni P, Meliga E, Goudreau E, Vetrovec G, Trevi GP, Sheiban I

November 20, 2007

1

Latest news

EAPCI consensus document on myocardial revascularisation failure; antegrade vs retrograde approach in CTO PCI and more…

December 4, 2020

Read the LEMON study

December 1, 2020

Repeat revascularisation: “An ounce of prevention is worth a pound of cure”

December 4, 2020

Popular Tavi-A, TAILOR-PCI, ATPCI, PORTICO-IDE and more

(Thanks to the support of Biotronik)

November 12, 2020

Guidance Papers

Guidelines, consensus & position papers

August 28, 2020

An obituary for Professor Tony Gershlick 1951-2020

December 1, 2020

This Week's JAA's: Balloon-based techniques for calcific CAD...

December 1, 2020

Valvular disease